Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported – Authors’ reply
Main Authors: | Nicola Creighton, Hanna E Tervonen, George W Zhao, David C Currow |
---|---|
Format: | Article |
Language: | English |
Published: |
Sax Institute
2020-06-01
|
Series: | Public Health Research & Practice |
Subjects: | |
Online Access: | https://doi.org/10.17061/phrp3022014 |
Similar Items
-
Capture of systemic anticancer medicines in Pharmaceutical Benefits Scheme (PBS) data likely higher than previously reported
by: Dominique L Favell, et al.
Published: (2020-06-01) -
Capture of systemic anticancer therapy use by routinely collected health datasets
by: Hanna E Tervonen, et al.
Published: (2020-03-01) -
Identifying Incident Cancer Cases in Medicine Dispensing Claims: A Validation Study Using Australia’s Pharmaceutical Scheme (PBS) Data
by: Benjamin Daniels, et al.
Published: (2020-12-01) -
Retrospective comparison of Australia’s Pharmaceutical Benefits Scheme claims data with prescription data in HER2-positive early breast cancer patients, 2008–2012
by: Carole Harris, et al.
Published: (2017-12-01) -
Benefits of Prescribed Fire
by: Michael G. Andreu, et al.
Published: (2023-06-01)